Dear customer, upon your request Onco Company were found the following resources. Our team makes effort to make you happy with the search on our site ninan.org

Home - OncoLog : OncoLog

PRODUCTS OncoLog Cancer Registry OncoLog Cancer Registry is a critical tool for cancer program analysis, administrative and clinical reporting and other day to day tasks in cancer data management. Our product meets increasing regulatory compliance and quality assurance reporting demands. LEARN MORE >> Abstracting Services Abstracting Services provides you with a staff of Abstracting Service ……

Onco Inc. LinkedIn

Learn about working at Onco Inc.. Join LinkedIn today for free. See who you know at Onco Inc., leverage your professional network, and get hired.…

Overview - OncoLog : OncoLog

ONCO Inc. was founded in 1983 by a physician with a dream. Radiation Oncologist, Dr. Ted Williamson envisioned an oncology data management system that was based on truly open access, unlimited flexibility, and outstanding customer support. All with one goal in mind: saving lives. A year later, that dream became reality.…

Making cancer care smarter with Oncotype DX tests ...

The only genomic test proven to predict a patient’s individual benefit from chemotherapy. For patients with early-stage, ER-positive, HER2-negative, node negative, and node-positive (1-3) breast cancer, the Oncotype DX Breast Recurrence Score quantifies the risk of distant recurrence and the likelihood of chemotherapy benefit.…

OncoDNA - Homepage

Feb 24, 2020 · OncoKDM is an online platform that turns the NGS data of the labs into actionable clinical information. Moreover, OncoKDM can integrate NGS results with IHC, MSI and TMB data. The resulting interactive report includes updated information about approved ……

Onco360 Oncology Pharmacy Onco360

Jan 24, 2020 · January 24, 2020. Epizyme has chosen Onco360 as the exclusive partner for TAZVERIK™ (tazemetostat), a new oral treatment for adult and pediatric patients (aged 16 years and older) with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.…